Paradox Immunotherapeutics (Investment)
Funding Details
- Awarder
- Inbox
- Date Award
- February 25, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $10,000,000
Company Info
- Organizations Involved
- SymBiosis Capital Management
- Founders
- Dr. Natalie Galant
- Company Description
- Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.
- Market
- Biotechnology
- Location
- Toronto, Canada